Q4 2024 Holdings
Filed 2025-02-14 | 68 holdings | $122.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $38.8M | 685,182 | 31.6% |
| Biodesix Inc | COM | 09075X108 | $8.5M | 5,581,176 | 7.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.2M | 338,400 | 5.1% |
| Elutia Inc(ELUT) | COM | 05479K106 | $4.6M | 1,225,489 | 3.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.2M | 304,574 | 3.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.1M | 30,240 | 3.4% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $3.7M | 74,000 | 3.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $3.5M | 10,000 | 2.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.2M | 197,000 | 2.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $3.2M | 764,062 | 2.6% |
| Quidelortho Corp | COM | 74838J101 | $3.0M | 67,619 | 2.5% |
| Phreesia Inc(PHR) | COM | 71944F106 | $2.9M | 114,700 | 2.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.6M | 148,000 | 2.1% |
| Masimo Corp(MASI) | COM | 574795100 | $2.5M | 15,280 | 2.1% |
| Harrow Health Inc(HROW) | COM | 415858109 | $2.4M | 72,910 | 2.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.3M | 210,000 | 1.9% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $2.1M | 52,200 | 1.7% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $2.1M | 78,000 | 1.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.9M | 48,000 | 1.5% |
| EQT Corporation(EQT) | COM | 26884L109 | $1.6M | 34,619 | 1.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.5M | 310,930 | 1.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 50,000 | 1.2% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $1.2M | 161,350 | 1.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $923.8K | 31,000 | 0.8% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $718.0K | 50,000 | 0.6% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $673.1K | 16,000 | 0.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $597.5K | 26,000 | 0.5% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $593.4K | 30,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $567.5K | 67,000 | 0.5% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $532.4K | 58,000 | 0.4% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $520.8K | 60,000 | 0.4% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $494.8K | 40,000 | 0.4% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $494.5K | 32,110 | 0.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $478.1K | 10,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $470.4K | 10,000 | 0.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $446.7K | 14,000 | 0.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $425.6K | 3,500 | 0.3% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $409.3K | 368,766 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $392.0K | 10,000 | 0.3% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $390.3K | 325,239 | 0.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $377.5K | 125,000 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $361.3K | 10,000 | 0.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $353.2K | 20,000 | 0.3% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $346.3K | 51,000 | 0.3% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $345.8K | 8,000 | 0.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $338.4K | 4,000 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $300.8K | 40,000 | 0.2% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $292.8K | 22,000 | 0.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $287.6K | 15,000 | 0.2% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $283.9K | 419,832 | 0.2% |